Caprolactam supplier will shed hundreds of jobs, while operations in Europe and China continue
New adhesives plant in Sweden and acquisition of Dutch firm Den Braven
Firms promise next-generation immuno-oncology as existing drugs rack up successes
Getting outraged at drug price hikes is all very well, but we need more constructive options
European commission extends license by 18 months
€3.2bn deal boosts Henkel’s position in North American laundry care market
Deal deepens Novartis’s focus on immuno-oncology
Offloading psoriasis and dermatitis antibodies continues AZ’s plan to refocus on fewer therapy areas
Generics deals with Impax, Dr Reddy’s and Sagent aimed at satisfying competition authorities
$3.2bn purchase from Albemarle continues BASF’s efforts to expand and refocus its coatings division
Deal worth up to $1.25bn includes drug candidate for chronic coughs
$3.3bn deal expands Johnson & Johnson’s consumer products segment
UK trade bodies predominantly favour remaining in the EU
$1bn deal with Renaissance Acquisition Holdings brings 25 products and builds on Meda merger portfolio
€950m deal pushes French oil giant deeper into renewables
Will GSK's move towards licensing patents in developing countries, rather than rigidly defending them, improve access to medicines?
Company profile: Qpinch reclaims wasted energy by mimicking nature
Five others injured when wastewater treatment device detonated
Should trade bodies do more than simply 'represent their members' interests'?
Drug discovery startup will contribute to cancer immunotherapy projects aimed at kinase enzymes
Bringing history to the table
Could the debate over pharma price-gouging have positive results for both patients and companies?
Whistleblower case relates to claims of Wyeth overcharging for acid reflux drugs between 2001 and 2006
€475 million deal includes technology, products and sites in the UK and South Africa